All articles tagged: Gonococcal cervicitis, unspecified (A54.03)
![]()
Evalytics
27 November at 05.37 PM
Will first FDA-approved at-home test for gonorrhea, chlamydia ease the epidemic?The FDA approved the first at-home test for chlamydia and gonorrhea, a significant step in addressing rising STI rates in the U.S. However, concerns about increased regulation potentially affecting availability and cost, and the test's limitations in covering all needs, particularly for syphilis and in the gay and bisexual community, remain points of debate. |
![]()
HealthDay
16 November at 09.53 PM
First OTC Test for Chlamydia, Gonorrhea Approved by the FDAOn Wednesday, the U.S. Food and Drug Administration granted marketing authorization to LetsGetChecked for the Simple 2 Test, the first home test for chlamydia and gonorrhea.People will be able to buy the Simple 2 Test over-the-counter at a pharmacy, take a specimen at home, and send their sample to a designated laboratory for testing, the FDA |
![]()
Evalytics
06 November at 03.16 PM
New antibiotic shows promise for drug-resistant gonorrheaA new antibiotic, zoliflodacin, has been shown to effectively treat drug-resistant gonorrhea in clinical trials and could become the first new treatment for the STI in decades, with the possibility of market availability by 2025. |
![]()
HealthDay
03 November at 11.00 PM
New Antibiotic Tackles Drug-Resistant Gonorrhea in TrialThe first new antibiotic for gonorrhea -- the second most common sexually transmitted disease -- has shown promise in a clinical trial.This new antibiotic, called zoliflodacin, was seen in the trial to cure uncomplicated gonorrhea infection as effectively as the current go-to treatment -- ceftriaxone along with one dose of azithromycin pills. |
![]()
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
![]()
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
![]()
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
![]()
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |